Valneva SE (VALN)
NASDAQ: VALN · IEX Real-Time Price · USD
7.67
+0.46 (6.35%)
Jul 22, 2024, 9:49 AM EDT - Market open
Valneva SE Employees
Valneva SE had 676 employees as of December 31, 2023. The number of employees decreased by 43 or -5.98% compared to the previous year.
Employees
676
Change (1Y)
-43
Growth (1Y)
-5.98%
Revenue / Employee
$245,945
Profits / Employee
-$39,222
Market Cap
533.54M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Community Health Systems | 61,000 |
Cross Country Healthcare | 13,131 |
Sharecare | 3,352 |
GRAIL, LLC | 1,360 |
Canopy Growth | 1,029 |
COMPASS Pathways | 186 |
Y-mAbs Therapeutics | 100 |
PureTech Health | 90 |
VALN News
- 9 hours ago - CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World's First Chikungunya Vaccine - GlobeNewsWire
- 3 days ago - Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026 - Benzinga
- 4 days ago - Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion - GlobeNewsWire
- 21 days ago - Valneva Receives Marketing Authorization in Europe for the World's First Chikungunya Vaccine, IXCHIQ® - GlobeNewsWire
- 25 days ago - Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board - GlobeNewsWire
- 4 weeks ago - Valneva Announces Health Canada Approval of the World's First Chikungunya Vaccine, IXCHIQ® - GlobeNewsWire
- 6 weeks ago - Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June - GlobeNewsWire